Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

Baxter to Provide Sterile Fill-Finish Services for Novavax's COVID-19 Vaccine

Baxter's Halle-Westfalen Facility to Manufacture Novavax Vaccine

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced it has entered into a manufacturing agreement with Novavax, Inc. to provide sterile fill-finish and packaging services for Novavax's COVID-19 vaccine. Baxter will utilize its state-of-the-art facility in Halle-Westfalen, Germany, to support Novavax's efforts to bring its vaccine to market. "We are proud to partner with Novavax to help accelerate the production of their COVID-19 vaccine," said Andrew Frese, president of Baxter's BioPharma Solutions business. "Our expertise in sterile manufacturing and global supply chain will help ensure that Novavax's vaccine is available to patients as quickly as possible." Baxter's Halle-Westfalen facility is a world-class manufacturer of sterile injectable products. The facility is ISO 14001-certified and has over 60 years of experience in sterile manufacturing. Baxter has invested significantly in the facility in recent years, including a major expansion in 2019 to support the growing demand for sterile injectable products. "Novavax is pleased to partner with Baxter, a global leader in sterile manufacturing," said Stanley C. Erck, President and Chief Executive Officer, Novavax. "Baxter's expertise and capabilities will be invaluable as we work to bring our COVID-19 vaccine to market." Baxter's collaboration with Novavax is part of the company's ongoing efforts to support the global fight against COVID-19. Baxter is also a leading supplier of intravenous immunoglobulin (IVIG), a plasma-derived therapy that is used to treat patients with compromised immune systems. IVIG is in high demand for the treatment of COVID-19 patients with severe immune dysregulation. About Baxter Baxter is a global healthcare company that provides a wide range of products and services to hospitals, dialysis centers, nursing homes, pharmacies, surgery centers and other healthcare providers. Baxter's products and services are used in the treatment of cancer, chronic and acute renal disease, hemophilia, immune disorders, infectious diseases, surgical and trauma procedures, and other conditions. Baxter has operations in more than 100 countries and employs approximately 55,000 people worldwide.